GIM
EDIT icon

Granahan Investment Management’s Editas Medicine EDIT Stock Holding History

Granahan Investment Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-125,183
Closed -$3.32M – 183
2021
Q4 		$3.32M Buy
125,183
+1,516
+1% +$52.2K 0.07% 169
2021
Q3 		$5.08M Sell
123,667
-14,599
-11% -$800K 0.1% 148
2021
Q2 		$7.83M Buy
138,266
+7,162
+5% +$265K 0.15% 129
2021
Q1 		$5.51M Sell
131,104
-24,098
-16% -$1.37M 0.12% 137
2020
Q4 		$10.9M Sell
155,202
-28,038
-15% -$1.15M 0.24% 86
2020
Q3 		$5.14M Buy
183,240
+112,935
+161% +$3.68M 0.17% 104
2020
Q2 		$2.08M Buy
70,305
+15,768
+29% +$412K 0.08% 151
2020
Q1 		$1.08M Sell
54,537
-808
-1% -$20.4K 0.06% 163
2019
Q4 		$1.64M Buy
55,345
+328
+0.6% +$8.19K 0.08% 147
2019
Q3 		$1.25M Buy
55,017
+4,221
+8% +$105K 0.07% 152
2019
Q2 		$1.26M Sell
50,796
-1,532
-3% -$36.6K 0.06% 161
2019
Q1 		$1.28M Sell
52,328
-3,825
-7% -$86.6K 0.07% 164
2018
Q4 		$1.28M Sell
56,153
-19,904
-26% -$542K 0.09% 153
2018
Q3 		$2.42M Sell
76,057
-1,498
-2% -$48.4K 0.13% 140
2018
Q2 		$2.78M Buy
77,555
+6,549
+9% +$232K 0.17% 140
2018
Q1 		$2.35M Sell
71,006
-35,195
-33% -$1.25M 0.17% 142
2017
Q4 		$3.26M Sell
106,201
-135,518
-56% -$3.41M 0.26% 117
2017
Q3 		$5.8M Buy
241,719
+15,999
+7% +$305K 0.48% 77
2017
Q2 		$3.79M Buy
+225,720
New +$4.07M 0.35% 96

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Granahan Investment Management's EDIT Position: Q1 2022 in Review

Granahan Investment Management sold out of Editas Medicine (EDIT) in Q1 2022, closing a stake of 125,183 shares — an estimated $3.32M sold.

Granahan Investment Management first reported a position in EDIT in Q2 2017 and held it in 19 quarters. The position peaked at $10.9M in Q4 2020. 256 funds tracked by Wall St. Rank hold EDIT as of Q1 2022.

  • Granahan Investment Management reported no remaining Editas Medicine position as of Q1 2022 after selling out during the quarter.
  • Granahan Investment Management sold 125,183 Editas Medicine shares in Q1 2022, an estimated $3.32M.
  • Granahan Investment Management first reported a position in Editas Medicine in Q2 2017 and held it in 19 quarters.
  • Granahan Investment Management's Editas Medicine position peaked at $10.9M in Q4 2020.
  • 256 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2022.

Based on Granahan Investment Management's 13F filing for Q1 2022, filed 16 May 2022.